Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

33
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
33
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

6.6K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.6K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

649
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
649
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

62
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ceramides and Type 2 Diabetes: A Scoping Review of Mechanisms, Insulin Resistance, and Nutritional Interventions.

Cureus·2026
Same author

Social robot design preferences as reported by stakeholders.

Frontiers in dementia·2026
Same author

Anti-cytomegalovirus medications among very low birth weight infants in the United States from 2016 to 2023.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Borrelia burgdorferi-Induced Neuroinflammation in Lyme Disease: A Potential Driver of Alzheimer's Disease Pathology?

Molecular neurobiology·2026
Same author

Large-Scale Mutagenesis Screening for Genetic Determinants of Plasmodium falciparum Sexual Development.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Heading in football matches: descriptive analysis of heading events from 687 matches across age groups in English Academy and First Team men's professional football.

British journal of sports medicine·2025
Same journal

Pleural Toxocariasis Presenting as Eosinophilic Pleural Effusion: A Case Report.

Cureus·2026
Same journal

Left Clavicular Pain Following Splenic Rupture After Colonoscopy: A Variant of Kehr's Sign?

Cureus·2026
Same journal

Severe Polyhydramnios Associated With Antenatal Bartter Syndrome.

Cureus·2026
Same journal

Focal Takotsubo Syndrome Mimicking a Distal Coronary Pathology: A Case Report.

Cureus·2026
Same journal

Metachronous Colorectal Carcinomas and Pancreatic Metastasis in Clinically Suspected Lynch Syndrome: An 18-Year Oncologic Course.

Cureus·2026
Same journal

Regional Blocks in the Era of the Opioid Crisis: Evaluating Their Opioid-Sparing Effect.

Cureus·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K

Neonatal Sepsis: Pathogens, Clinical Challenges, and Emerging Solutions.

Matthew Green1, Jyotsna Chawla1, Cyril Blavo1

  • 1Foundational Sciences, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Clearwater, USA.

Cureus
|March 30, 2026
PubMed
Summary
This summary is machine-generated.

Neonatal sepsis is a leading cause of newborn deaths. Innovations in diagnostics, vaccines, and therapies offer new hope for prevention and treatment, but equitable access is crucial.

Keywords:
antibiotic therapyearly-onset sepsisescherichia coliglobal healthgroup b streptococcuslate-onset sepsislisteria monocytogenesneonatal infection control

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

582

Related Experiment Videos

Last Updated: Mar 31, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

582

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Neonatal sepsis causes significant preventable newborn mortality globally.
  • Challenges include diagnostic delays, antimicrobial resistance (AMR), and resource inequality.
  • Urgent need for novel strategies to combat neonatal infections.

Purpose of the Study:

  • To review pathogens, transmission, and clinical aspects of neonatal sepsis.
  • To examine emerging innovations for sepsis prevention and treatment.
  • To advocate for standardized protocols and equitable global implementation.

Main Methods:

  • Literature review of neonatal sepsis pathogens and clinical presentations.
  • Analysis of advancements in diagnostics (molecular, NGS), AI, maternal vaccination, and immunotherapies.
  • Synthesis of current evidence to identify global care gaps.

Main Results:

  • Identified primary pathogens and their characteristics in early- and late-onset sepsis.
  • Highlighted potential of new technologies like rapid diagnostics and AI.
  • Emphasized the role of maternal vaccination and immunotherapies.

Conclusions:

  • Innovations offer transformative potential for neonatal sepsis management.
  • Standardized protocols and equitable access are essential for global impact.
  • Reducing the global burden of neonatal sepsis requires integrated advancements.